Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Expert Review of Medical Devices|December 21, 2018
A cost-effectiveness analysis of the use of safety-engineered syringes in reducing HBV, HCV, and HIV burden in EgyptAya Mostafa, Gihan Hamdy ElsisiGlobal Journal on Quality and Safety in Healthcare|November 14, 2025
Data Classification Methodology: The Way Forward to Data-Enabled Healthcare in EgyptGihan Hamdy Elsisi, Yousra HamedValue in Health Regional Issues|October 28, 2017
Cost-Effectiveness Analysis of New HCV Treatments in Egyptian Cirrhotic and Non-Cirrhotic Patients: A Societal PerspectiveGihan Hamdy Elsisi, Asmaa Aburawash, Emam WakedExpert Review of Pharmacoeconomics & Outcomes Research|December 4, 2020
Budget impact analysis of subcutaneous trastuzumab compared to intravenous trastuzumab in Saudi HER2-positive breast cancer patientsShereef Elsamany, Gihan Hamdy Elsisi, Fayza Hassanin, et al.Journal of Medical Economics|March 12, 2024
The economic burden of systemic lupus erythematosus in TaiwanGihan Hamdy Elsisi, Song-Chou Hsieh, Der-Yuan ChenJournal of Medical Economics|October 23, 2024
Budget impact analysis on the use of Sysmex PA-100 AST system as a point of care for uncomplicated urinary tract infections detection and treatment in Spanish femalesGihan Hamdy Elsisi, Hanan Saady Zaky, José Medina PoloJournal of Medical Economics|November 28, 2018
Cost-effectiveness of sorafenib versus best supportive care in advanced hepatocellular carcinoma in EgyptGihan Hamdy Elsisi, Yousery Nada, Noha Rashad, et al.Journal of Medical Economics|March 12, 2024
Microsimulation model of the cost-effectiveness of anifrolumab compared to belimumab in the United Arab EmiratesGihan Hamdy Elsisi, Ahmed Abogamal Waleed, Walid Al Shehhy, et al.Journal of Medical Economics|March 12, 2024
Clinical and economic burden of systemic lupus erythematosus in ColombiaGihan Hamdy Elsisi, Gerardo Quintana, Diana Gil, et al.Global Journal on Quality and Safety in Healthcare|February 26, 2024
Overview of Procurement and Reimbursement of Pharmaceuticals in Saudi Arabia, United Arab Emirates, Qatar, and Egypt: Challenges and OpportunitiesAnas Hamad, Mai Alsaqa'aby, Yazed Alruthia, et al.Pageof 3